Monday, August 20, 2018
 
 
Company News: Page (1) of 1 - 05/16/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Global Artificial Organs Market Overview 2018: Market Size, Share, Growth, Trends, Opportunities and Forecast To 2023

(May 16, 2018)


"Global Artificial Organs Market Stimulated by Technological Advancements"
The global artificial organs market has grown at a healthy rate, over the recent years. Some of the factors influencing the market growth include increasing geriatric population, expanding healthcare facilities, rising cases of accidents, etc.

An artificial organ is an engineered device which is implanted into the human body to replace a natural organ in case of failure or a disease. The lack in the availability of natural organs for a transplant has been a serious concern over the years, as the demand for organs for replacement/transplant is very high as compared to the supply. Apart from organ scarcity, finding a compatible organ also poses problems for the patients. Owing to these factors, the demand for artificial organs has witnessed a significant surge. A new research report by IMARC Group, titled “Artificial Organs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023” estimates that the artificial organs market was worth US$ 12 Billion in 2017. The report further anticipates the market to cross US$ 21 Billion by 2023, at a projected CAGR of 9.5% over the forecast period.

Global Artificial Organs Market Drivers/Constraints:

  • One of the primary factors propelling the growth of the artificial organs market is the increasing cases of disabilities as well as organ failures. Apart from this, technological advancements in the development of artificial organs has further proliferated their demand.
  • The unavailability of organ donors at the time of need and the difficulties in matching different biological factors have encouraged the development of artificial organs across the globe. Moreover, the ability of the artificial organs in retaining usual functioning of the human body is supporting the market growth.
  • Some of the other factors influencing the demand for artificial organs include changing lifestyle, rising geriatric population, increasing cases of accidents, emerging healthcare facilities and expanding medical expenditure.
  • There are several factors that hamper the growth of the market. For instance, the high implantation cost and limited surgical expertise can restrain the demand for artificial organs.

Product Type Insights:

On the basis of type, the artificial organs market is segregated as artificial kidney, artificial heart, artificial pancreas, cochlear implants and others. Currently, artificial kidney represents the leading product on account of high demand resulting from increasing cases of kidney failure.

Want more information about this market? Request a free report sample

Regional Insights:

On a geographical front, North America represents the dominant market, accounting for the largest global share. The higher healthcare expenditure in the region coupled with increased awareness regarding artificial organs act as the key factors driving market growth in North America. It is followed by Europe, Asia Pacific, Latin America, Middle East and Africa.

Competitive Landscape:

The market is highly concentrated with the presence of few large manufacturers who compete in terms of prices and quality. There is a tough competition in the market which makes it difficult for small players to enter the market. Some of the leading players operating in the market are:

  • Abiomed, Inc.
  • Heartware International, Inc.
  • Edwards Lifesciences Corp
  • Boston Scientific Corporation
  • Cochlear Limited



Browse related reports:

Hormone Replacement Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023

Colostomy Bags Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Media Contact


Company Name: IMARC Group
Contact Person: Anand Ranjan
Email: [email protected]
Phone: +1-631-791-1145
Country: United States
Website: https://www.imarcgroup.com/



Source: www.abnewswire.com


Page: 1


Related Keywords:Europe,Health & Medicine,Manufacturing & Industry,Pharmaceuticals & Biotech,U.S,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • Global Hemodialysis and Peritoneal Dialysis Market to Witness a CAGR of 5.9% during 2018-2024
  • The Alzheimer's Research and Prevention Foundation (ARPF) Announces Second Brain Longevity® Therapy Training Program in Washington D.C.
  • Image Guided Radiotherapy Market to Experience Unfaltering Growth at 15.8% CAGR to Revolutionize the Healthcare Sector by 2023
  • Disposable Negative Pressure Wound Therapy Devices Market: Global Industry Analysis (2012 - 2016) & Opportunity Assessment (2017 - 2027)

    Cancer
  • Information Update - Teva Canada expands recall of valsartan drugs to include additional lots, as a precaution
  • Singapore's first clinical trial approval for T cell engineered (TCR) immunotherapy for treatment of Liver cancer
  • ViewRay Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock
  • Mirati Therapeutics Announces Presentation Of KRAS G12C Chemistry Advances At The 255th American Chemical Society (ACS) National Meeting And Exposition
  • Agenus Receives Second Milestone Payment from Merck
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines